NBT Bank »

Acumen Pharmaceuticals shares owned by NBT Bank

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by NBT Bank from 13F filings

Historical chart of NBT Bank investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by NBT Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by NBT Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $342 2 171.00
2025-06-30 $232 200 1.16

More positions owned by NBT Bank

Schwab International Equity ETF (SCHF)
Apple (AAPL)
Vaneck Vectors Etf Tr fallen angel hg (ANGL)
iShares MSCI EAFE Growth Index (EFG)
Schwab U S Small Cap ETF (SCHA)
Exxon Mobil Corporation (XOM)
iShares iBoxx $ High Yid Corp Bond (HYG)
U.S. Bancorp (USB)
Johnson & Johnson (JNJ)
Vanguard Value ETF (VTV)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Microsoft Corporation (MSFT)
Sch Us Mid-cap Etf etf (SCHM)
Raytheon Technologies Corp (RTX)
Caterpillar (CAT)

View all positions for NBT Bank

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
FMR
Vanguard Group
Knollwood Investment Advisory
Alyeska Investment Group
ADAR1 Capital Management
Laurion Capital Management
Pathstone Holdings
Hudson Bay Capital Management
Millennium Management
Renaissance Technologies
Citadel Advisors
Two Sigma Advisers

View all funds holding Acumen Pharmaceuticals